Investors Are Watching: Macrocure Ltd. (NASDAQ:MCUR), Exelixis, Inc. (NASDAQ:EXEL), Vulcan Materials Company (NYSE:VMC), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Fluor Corporation (NYSE:FLR)

Macrocure Ltd. (NASDAQ:MCUR) belongs to Healthcare sector. Its weekly performance is -4.79%. On last trading day company shares ended up $13.11. Macrocure Ltd. (NASDAQ:MCUR) distance from 50-day simple moving average (SMA50) is 8.37%. Oppenheimer set a $20.00 target price on Macrocure (NASDAQ:MCUR) in a report issued on Wednesday. The firm currently has a a buy rating on the stock.

Exelixis, Inc. (NASDAQ:EXEL) shares increased 2.99% in last trading session and ended the day at $3.79. EXEL Gross Margin is 91.60% and its return on assets is -63.90%. Exelixis, Inc. (NASDAQ:EXEL) quarterly performance is 20.70%. Exelixis, Inc. (NASDAQ:EXEL) announced the initiation of a phase 1 trial of cabozantinib in combination with nivolumab alone or in combination with nivolumab plus ipilimumab in patients with advanced/metastatic urothelial (bladder) and other genitourinary tumors. The primary endpoint of the trial is the determination of dose-limiting toxicities (DLT) and a recommended phase 2 dose (RP2D) for the combination of cabozantinib and nivolumab, and separately, for the combination of cabozantinib, nivolumab and ipilimumab, in patients with genitourinary solid tumors.

On 13 July, Vulcan Materials Company (NYSE:VMC) shares increased 0.08% and was closed at $90.43. VMC EPS growth in last 5 year was 57.70%. Vulcan Materials Company (NYSE:VMC) year to date (YTD) performance is 37.90%. Vulcan Materials (NYSE: VMC) declared a quarterly dividend of $0.10 per share, or $0.4 annualized. The dividend will be payable on September 10, 2015, to stockholders of record on August 25, 2015, with an ex-dividend date of August 21, 2015.

KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) ended the last trading day at $0.39. Company weekly volatility is calculated as 12.28% and price to cash ratio as 0.43. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) showed a weekly performance of -18.73%.KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), announced that it will effect a reverse stock split at a ratio of one share of newly issued common stock for each eight shares of issued and outstanding common stock.

Fluor Corporation (NYSE:FLR) shares moved up 1.42% in last trading session and ended the day at $51.46. FLR Gross Margin is 6.70% and its return on assets is 6.30%. Fluor Corporation (NYSE:FLR) quarterly performance is -11.46%. Fluor Corporation (NYSE:FLR) has been selected to be part of the US Air Force Contract Augmentation Program IV (AFCAP IV) for six years. The contract begins from October 1, 2015, the company announced.

Leave a Reply

Your email address will not be published. Required fields are marked *